HIV Research: Join Clinical Studies

Title: Driving HIV Research Forward with the Actuel Medical Clinic

The Actuel Medical Clinic is calling on patients to participate in research studies aimed at improving HIV treatment and prevention methods like Pre-Exposure Prophylaxis (PrEP). We spoke to Dr. Sam Kajjo, the academic and clinical research coordinator at the clinic, about these efforts and the importance they hold for the community.

Dr. Kajjo, who has been coordinating the research team for the past six months, emphasizes the dedication of the team. With seven members, it’s a dynamic group focused on helping individuals affected by HIV. Growing up in Syria, where it was unsafe to openly identify as LGBTQ+, Dr. Kajjo moved to Canada 12 years ago and is now grateful to work alongside esteemed professionals such as Dr. Réjean Thomas, the clinic’s founder, and Dr. Jason Szabo, the research director.

The clinic has 12 ongoing clinical studies, with more set to begin in 2025. Patients can express their interest through their regular medical visits, ensuring all personal data remains anonymous. Dr. Kajjo’s background in biology, chemistry, and an HIV-focused PhD fuels his passion for helping those living with HIV. Current studies include investigating long-term injectable treatments to boost immunity and enhance adherence, as well as research targeting individuals who engage in ‘chemsex.’

One notable study is ‘Cheers,’ which aims to connect ‘chemsex’ practitioners with helpful psychosocial services. So far, 15 participants have joined within a month. Another long-term study, ‘Québec Don de sang,’ is exploring how HIV-positive individuals can safely donate blood, in collaboration with Sainte-Justine Hospital.

Héma-Québec, the blood donor organization, currently prohibits blood donation from men on PrEP, assuming they might be sexually active and potential carriers of sexually transmitted infections (STIs). The ‘Québec Don de sang’ study aims to prove that PrEP users are not at higher risk than other populations and may even be more protected due to regular check-ups.

Currently, those on PrEP must cease treatment for four months for blood donation, with a 2-year wait for injectable PrEP users. However, stopping PrEP can lead to new infections. This study, with 300 participants and an aim of 600, seeks scientific data on safe donation intervals.

Future studies, like PSHARSAH and NOVA, will target migrant communities, aiming to enroll 200-300 patients. The goal is to inform migrants about PrEP and protect them from infection.

All studies aim to improve HIV-positive individuals’ quality of life, reduce transmissions, and fighting stigma. The clinic’s extensive database collects anonymous patient data, enabling breakthroughs in treatments and care tailored to various intersections of HIV with other conditions.

Contact Information:
Actuel Medical Clinic
1001, boulevard de Maisonneuve Est, Montréal, 11th floor, bureau 1130
Phone: 514-524-1001
Website: cliniquelactuel.com

A Brighter Future for All: Join the Fight Against HIV

The Actuel Medical Clinic’s commitment⁣ to advancing HIV research through patient participation is⁢ a beacon of hope for individuals affected by the virus and the wider community. Dr.Kajjo’s own journey, fueled by passion ⁢and a desire to make a difference, underscores⁣ the personal connection driving these crucial efforts.By⁢ joining research studies, patients ⁢empower ⁣themselves to contribute to better treatments, more⁣ effective prevention strategies like PrEP, and ultimately, a future where HIV no ⁣longer poses a threat. their ‍participation is not just about scientific progress; it’s about building a more inclusive and equitable world for all.

Let us all join hands ‍with the courageous individuals at Actuel Medical Clinic and support their mission to drive HIV research forward.Together, we can rewrite the‍ narrative‍ surrounding this disease and build a brighter future for everyone.
The Actuel Medical Clinic stands as a beacon of hope and progress in the fight against HIV, demonstrating the power of dedicated research and community engagement. through groundbreaking studies like “Cheers” and “Québec Don de sang,” the clinic is not only advancing medical treatment but also tackling the social stigma and challenges faced by individuals living with HIV. By actively involving patients in research, Actuel empowers individuals to become active participants in their own healthcare and contributes to a future where HIV is no longer a barrier to a long and healthy life.The clinic’s commitment to innovation and inclusivity serves as an inspiration to the broader healthcare community, reminding us that with collective effort and unwavering dedication, we can continue to drive progress in the fight against HIV.